Colorectal cancer screening use among insured adults: Is out-of-pocket cost a barrier to routine screening?

被引:1
|
作者
Abhilash Perisetti [1 ]
Hafiz Khan [2 ]
Nayana E George [3 ]
Rachana Yendala [4 ]
Aamrin Rafiq [5 ]
Summre Blakely [6 ]
Drew Rasmussen [2 ]
Nathan Villalpando [2 ]
Hemant Goyal [7 ]
机构
[1] Department of Gastroenterology, University of Arkansas for Medical Sciences
[2] Department of Internal Medicine, Mercer University School of Medicine
[3] Department of Biological Sciences, Texas Tech University
[4] Department of Hematology and Oncology, Texas Tech University Health Sciences
[5] Department of Public Health, Texas Tech University Health Sciences
[6] Department of Internal Medicine, University of Arkansas Medical Sciences
[7] School of Medicine, Texas Tech University Health Sciences Center
关键词
Fecal occult blood; Healthcare delivery; Sigmoidoscopy; Colorectal cancer; Screening; Access to care; Behavioral Risk Factor Surveillance System;
D O I
暂无
中图分类号
R735.34 [];
学科分类号
100214 ;
摘要
AIM To describe the characteristics of adults who needed to see a doctor in the past year but could not due to the extra cost and assess the impact of limited financial resources on the receipt of routine fecal occult blood test, sigmoidoscopy, or colonoscopy for colon cancer screening among insured patients. METHODS Data obtained from the 2012 Behavioral Risk Factor Surveillance System included 215436 insured adults age 50-75 years. We computed frequencies, adjusted odds ratios(a ORs), and 95%CIs using SAS v9.3 software. RESULTS Nine percent of the study population needed to see a doctor in the past year but could not because of cost. The numbers were significantly higher among those aged 50-64(P < 0.0001), Non-Hispanic Whites(P < 0.0001), and those with a primary care physician(P < 0.0001) among other factors. Adjusting for possible confounders, a ORs for not seeing the doctor in the past year because of cost were: stool occult blood test within last year a OR = 0.88; 95%CI: 0.76-1.02, sigmoidoscopy within last year a OR = 0.72; 95%CI: 0.48-1.07, colonoscopy within the last year a OR = 0.91; 95%CI: 0.81-1.02. CONCLUSION We found that the limited financial resources within the past 12 mo were significantly associated with colorectal cancer(CRC) non-screening. Patients with risk factors identified in this study should adhere to CRC guidelines and should receive financial help if needed.
引用
收藏
页码:31 / 38
页数:8
相关论文
共 50 条
  • [31] Out-of-Pocket Health Expenditures Among Insured and Uninsured Patients in Vietnam
    Nguyen Duc Thanh
    Bui Thi My Anh
    Chu Huyen Xiem
    Hoang Van Minh
    ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH, 2019, 31 (03) : 210 - 218
  • [32] Out-of-Pocket Spending for Deliveries and Newborn Hospitalizations Among the Privately Insured
    Chua, Kao-Ping
    Fendrick, A. Mark
    Conti, Rena M.
    Moniz, Michelle H.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2022, 77 (01) : 11 - 13
  • [33] Total and Out-of-Pocket Costs of Procedures After Lung Cancer Screening in a National Commercially Insured Population: Estimating an Episode of Care
    Tailor, Tina D.
    Bell, Sarah
    Fendrick, A. Mark
    Carlos, Ruth C.
    JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, 2022, 19 (01) : 35 - 46
  • [34] Out-of-Pocket Spending for Deliveries and Newborn Hospitalizations Among the Privately Insured
    Chua, Kao-Ping
    Fendrick, A. Mark
    Conti, Rena M.
    Moniz, Michelle H.
    PEDIATRICS, 2021, 148 (01)
  • [35] Screening Colonoscopy Among Colorectal Cancer Survivors Insured by Medicaid
    Foley, Kristie Long
    Song, Eun-Young
    Klepin, Heidi
    Geiger, Ann
    Tooze, Janet
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (03): : 205 - 211
  • [36] Out-of-Pocket Costs of Treatment Among Employer-Insured Women With Invasive Breast Cancer
    Hager, Audrey
    Gracia, Gabriela
    Rodin, Danielle
    Conti, Rena M.
    JAMA NETWORK OPEN, 2023, 6 (03) : E231507
  • [37] Out-of-Pocket Costs of Diagnostic Breast Imaging Services After Screening Mammography Among Commercially Insured Women From 2010 to 2017
    Lowry, Kathryn P.
    Bell, Sarah
    Fendrick, A. Mark
    Carlos, Ruth C.
    JAMA NETWORK OPEN, 2021, 4 (08) : E2121347
  • [38] Maxed out: Reaching the annual maximum out-of-pocket limit among insured patients diagnosed with cancer.
    Banegas, Matthew P.
    Dickerson, John F.
    Petrik, Amanda F.
    Anderson, Melissa L.
    Keast, Erin
    Ramaprasan, Arvind
    Wallace, Jamie
    Henrikson, Nora B.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [39] Out-of-pocket costs for commercially insured patients with localized prostate cancer
    Wallis, Christopher J. D.
    Joyce, Daniel D.
    Klaassen, Zachary
    Luckenbaugh, Amy N.
    Laviana, Aaron A.
    Penson, David
    Dusetzina, Stacie B.
    Barocas, Daniel A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (12) : 797 - 805
  • [40] Out-of-Pocket Spending for Hospitalizations Among Nonelderly Adults
    Adrion, Emily R.
    Ryan, Andrew M.
    Seltzer, Amanda C.
    Chen, Lena M.
    Ayanian, John Z.
    Nallamothu, Brahmajee K.
    JAMA INTERNAL MEDICINE, 2016, 176 (09) : 1325 - 1332